Cited by 591Pancreatic and Hepatic Oncology ResearchCancer Genomics and DiagnosticsBreast Cancer Treatment Studies

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features

Puleo, Francesco, Nicolle, Rémy, Blum, Yuna, Cros, Jérôme, Marisa, Laetitia, Demetter, Pieter, Quertinmont, Eric, Svrcek, Magali, Elarouci, Nabila, Iovanna, Juan, Franchimont, Denis, Verset, Laurine, Galdon, Maria Gomez, Devière, Jacques, de Reyniès, Aurélien, Laurent-Puig, Pierre, Van Laethem, Jean-Luc, Bachet, Jean-Baptiste, Maréchal, Raphaël·2018·Gastroenterology

DOI 10.1053/j.gastro.2018.08.033

Open this paper in CoChat — free account

Abstract

Background & aims Genomic studies have revealed subtypes of pancreatic ductal adenocarcinoma (PDA) based on their molecular features, but different studies have reported different classification systems. It is a challenge to obtain high-quality, freshly frozen tissue for clinical analysis and determination of PDA subtypes. We aimed to redefine subtypes of PDA using a large number of formalin-fixed and paraffin-embedded PDA samples, which are more amenable to routine clinical evaluation.Methods We collected PDA samples from 309 consecutive patients who underwent surgery from September 1996 through December 2010 at 4 academic hospitals in Europe; nontumor tissue samples were not included. Samples were formalin fixed and paraffin embedded. DNA and RNA were isolated; gene expression, targeted DNA sequencing, and immunohistochemical analyses were performed. We used independent component analysis to deconvolute normal, tumor, and microenvironment transcriptome patterns in samples. We devised classification systems from an unsupervised analysis using a consensus clustering approach of our data set after removing normal contamination components. We associated subtypes with overall survival and disease-free survival of patients using Cox proportional hazards regression with estimation of hazard ratios and 95% confidence interval. We used The Cancer Genome Consortium and International Cancer Genome Consortium PDA data sets as validation cohorts.Results We validated the previously reported basal-like and classical tumor-specific subtypes of PDAs. We identified features of the PDA, including microenvironment gene expression patterns, that allowed tumors to be categorized into 5 subtypes, called pure basal like, stroma activated, desmoplastic, pure classical, and immune classical. These PDA subtypes have features of cancer cells and immune cells that could be targeted by pharmacologic agents. Tumor subtypes were associated with patient outcomes, based on analysis of our data set and the International Cancer Genome Consortium and The Cancer Genome Consortium PDA data sets. We also observed an exocrine signal associated with acinar cell contamination (from pancreatic tissue).Conclusions We identified a classification system based on gene expression analysis of formalin-fixed PDA samples. We identified 5 PDA subtypes, based on features of cancer cells and the tumor microenvironment. This system might be used to select therapies and predict patient outcomes. We found evidence that the previously reported exocrine-like (called ADEX) tumor subtype resulted from contamination with pancreatic acinar cells. ArrayExpress accession number: E-MTAB-6134.

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2018.08.033

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cancer Statistics, 2017.
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Inferring tumour purity and stromal and immune cell admixture from expression data
Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3612 · Cited by 9,778
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Le, D. T., Durham, J. N., Smith, K. N., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., et al. (2017) · Science · doi:10.1126/science.aan6733 · Cited by 6,645
The <tt>sva</tt> package for removing batch effects and other unwanted variation in high-throughput experiments
Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E., & Storey, J. D. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts034 · Cited by 6,231
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Wilkerson, M. D., & Hayes, D. N. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq170 · Cited by 5,645
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
Self-citation
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Becht, É., Giraldo, N. A., Lacroix, L., Buttard, B., Elarouci, N., Petitprez, F., Sèlves, J., Laurent‐Puig, P., Sautès‐Fridman, C., Fridman, W. H., et al. (2016) · Genome biology · doi:10.1186/s13059-016-1070-5 · Cited by 3,677
Self-citation
Genomic analyses identify molecular subtypes of pancreatic cancer
Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170

Flagged first, then by citations

Show all 34 references

Research works printed but not linked: 3

Nicolle, 2017, Pancreatic adenocarcinoma therapeutic targets revealed by tumor-stroma cross-talk analyses in patient-derived xenografts, Cell Rep, 21, 2458, 10.1016/j.celrep.2017.11.003 · DOI
Bailey, 2016, Genomic analyses identify molecular subtypes of pancreatic cancer, Nature, 531, 47, 10.1038/nature16965 · DOI · Paper page
Moffitt, 2015, Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma, Nat Genet, 47, 1168, 10.1038/ng.3398 · DOI · Paper page

Sorted by citations

Items 301–400 of 591

Artificial intelligence-based analysis of time-lapse images of sphere formation and process of plate adhesion and spread of pancreatic cancer cells
Shichi, Y., Gomi, F., Hasegawa, Y., Nonaka, K., Shinji, S., Takahashi, K., & Ishiwata, T. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1290753 · Cited by 8
Cell of Origin of Pancreatic cancer
Zheng, C., Wang, J., Wang, J., Zhang, Q., & Liang, T. (2024) · Pancreas · doi:10.1097/mpa.0000000000002301 · Cited by 12
Predictive genomic and transcriptomic analysis on endoscopic ultrasound-guided fine needle aspiration materials from primary pancreatic adenocarcinoma: a prospective multicentre study
Nicolle, R., Canivet, C., Palazzo, L., Napoléon, B., Ayadi, M., Pignolet, C., Cros, J. F., Gourgou, S., Sèlves, J., Torrisani, J., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105373 · Cited by 8
Self-citation
Apolipoprotein B Is Associated With the Microenvironment of Cholangiocarcinoma
Xu, X., Chen, D., Feng, X., Hu, J., Ge, J., Yan, C., Zhang, D., Ling, Z., Chen, J., & Wu, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.654689 · Cited by 8
BRCA1 and RAD51C promotor methylation in human resectable pancreatic adenocarcinoma
Abdallah, R., Zhao, S., Garinet, S., Hormigos, K., Corre, D. L., Cros, J. F., Perez‐Toralla, K., Bats, A., Augustin, J., Bachet, J., et al. (2022) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2022.101880 · Cited by 8
Self-citation
Identification of Carcinogenesis and Tumor Progression Processes in Pancreatic Ductal Adenocarcinoma Using High-Throughput Proteomics
Trilla‐Fuertes, L., Gámez‐Pozo, A., Lumbreras-Herrera, M. I., López‐Vacas, R., Heredia-Soto, V., Ghanem, I., López‐Camacho, E., Zapater‐Moros, A., de Miguel, M., Pena‐Burgos, E. M., et al. (2022) · Cancers · doi:10.3390/cancers14102414 · Cited by 8
p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer
Miller, P., Akama‐Garren, E. H., Owen, R. P., Demetriou, C., Carroll, T. M., Slee, E. A., Moussawi, K. A., Ellis, M., Goldin, R. D., O’Neill, E. E., et al. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01168-3 · Cited by 8
The Role of Endoscopic Ultrasound in Pancreatic Cancer Staging in the Era of Neoadjuvant Therapy and Personalised Medicine
Bispo, M., Marques, S., Rio‐Tinto, R., Fidalgo, P. O., & Deviere, J. M. E. (2020) · GE Portuguese Journal of Gastroenterology · doi:10.1159/000509197 · Cited by 8
Molecular Subtypes of Pancreatic Cancer: A Proteomics Approach
Thakur, R. K., & Singh, P. K. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0640 · Cited by 8
Refining Classification of Pancreatic Cancer Subtypes to Improve Clinical Care
Aguirre, A. J. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.11.004 · Cited by 8
Ras-dependent activation of BMAL2 regulates hypoxic metabolism in pancreatic cancerPreprint
Curiel-Garcia, A., Holmstrom, S. R., Castillo, C., Palermo, C. F., Sastra, S. A., Andren, A. C., Tomassoni, L., Zhang, L., Large, T. Y. S. L., Sagalovskiy, I. R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.19.533333 · Cited by 7
Real-World Validation of the Purity Independent Subtyping of Tumors Classifier for Informing Therapy Selection in Pancreatic Ductal Adenocarcinoma
Wenric, S., Sangli, C., Guittar, J. L., Islam, F., Zander, A. D., Hyun, S. W., Davison, J. M., Mayhew, G. M., Beebe, K. D., Beauchamp, K. A., et al. (2025) · JCO Precision Oncology · doi:10.1200/po-25-00197 · Cited by 7
Tumor microenvironment subtyping in pancreatic ductal adenocarcinoma: New avenues for personalized therapeutic strategies
Srinivasan, D., Gout, J., Kleger, A., & Roger, É. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115697 · Cited by 7
Netrin1 blockade alleviates resistance to chemotherapy in pancreatic cancer
Roth, G. S., Artru, P., Bouché, O., Williet, N., Ghelfi, J., Turpin, A., Lièvre, A., Blanc, J., Evrard, C., Bachet, J., et al. (2026) · Nature · doi:10.1038/s41586-026-10436-4 · Cited by 9
Self-citation
A Lesson in Transcriptional Plasticity: Classical Identity Is Silenced, but Not Lost, in Pancreatic Ductal Adenocarcinoma Cell Lines
Baba, T., Finetti, P., Birnbaum, D. J., Bertucci, F., Lillemoe, K. D., Warshaw, A. L., Castillo, C. F.-D., & Liss, A. S. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.07.005 · Cited by 7
The Role of Hyponatraemia Before Surgery in Patients With Radical Resected Pancreatic Cancer
Berardi, R., Rinaldi, S., Belfiori, G., Partelli, S., Crippa, S., Torniai, M., & Falconi, M. (2020) · Clinical Medicine Insights Oncology · doi:10.1177/1179554920936605 · Cited by 7
Beyond the Front Line: Emerging Data for Maintenance Therapy in Pancreatic Cancer
Singh, H., Perez, K. J., Wolpin, B. M., & Aguirre, A. J. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.01510 · Cited by 7
Incidental nonfunctioning pancreatic neuroendocrine tumors: Contrast enhanced ultrasound features in diagnosis1
Yang, D., Wang, D., Qiu, Y., Tian, X., Zuo, D., Dong, Y., Lou, W., & Wang, W. (2021) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-211269 · Cited by 7
Context Matters—Why We Need to Change From a One Size Fits all Approach to Made-to-Measure Therapies for Individual Patients With Pancreatic Cancer
Sankarasubramanian, S., Pfohl, U., Regenbrecht, C. R. A., Reinhard, C., & Wedeken, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.760705 · Cited by 7
3D In Vivo Models for Translational Research on Pancreatic Cancer: The Chorioallantoic Membrane (CAM) Model
Pion, E., Karnosky, J., Boscheck, S., Wagner, B. J., Schmidt, K. M., Brunner, S. M., Schlitt, H. J., Aung, T., Hackl, C., & Haerteis, S. (2022) · Cancers · doi:10.3390/cancers14153733 · Cited by 7
Single Cell RNA Sequencing: A New Frontier in Pancreatic Ductal Adenocarcinoma
Zerdan, M. B., Shatila, M., Sarwal, D., Bouferraa, Y., Zerdan, M. B., Allam, S., Ramovic-Zobic, M., & Graziano, S. L. (2022) · Cancers · doi:10.3390/cancers14194589 · Cited by 7
Clinical significance and functional role of adhesion G-protein-coupled receptors in human pancreatic ductal adenocarcinoma
Nishiwada, S., Shimura, T., Yamamura, K., Nakagawa, K., Nagai, M., Nakamura, K., Terai, T., Yamada, S., Fujii, T., Kodera, Y., et al. (2022) · British Journal of Cancer · doi:10.1038/s41416-022-02057-1 · Cited by 7
Deeper insights into long-term survival heterogeneity of pancreatic ductal adenocarcinoma (PDAC) patients using integrative individual- and group-level transcriptome network analyses
Bhardwaj, A., Josse, C., Daele, D. V., Poulet, C., Chavez, M., Struman, I., & Steen, K. V. (2022) · Scientific Reports · doi:10.1038/s41598-022-14592-1 · Cited by 7
CAFomics: convergence to translation for precision stroma approaches
McCabe, I. C., Peng, X. L., Kearney, J. F., & Yeh, J. J. (2024) · Carcinogenesis · doi:10.1093/carcin/bgae063 · Cited by 6
KRAS inhibition reverses chemotherapy resistance promoted by therapy-induced senescence-like in pancreatic ductal adenocarcinoma
Abuelafia, A. M., Santofimia‐Castaño, P., Estarás, M., Grasso, D., Chuluyán, E., Lomberk, G. A., Urrutia, R. A., Dusetti, N., Fraunhoffer, N. A., & Iovanna, J. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102421 · Cited by 6
Self-citation
Domestication and feedback: bidirectional hijacking in pancreatic ductal adenocarcinoma microenvironment
Qiao, Y., Yin, H., Zhang, Y., Zhang, J., & Dong, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1585858 · Cited by 8
ECM-responsive nanomedicine to enhance immunotherapy in pancreatic cancer
Li, L., Wen, J., Xu, H., Yu, H., Bai, X. L., & Zhang, Y. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.115356 · Cited by 7
An integrated analysis identifies six molecular subtypes of pancreatic ductal adenocarcinoma revealing cellular and molecular landscape
Li, L., Shen, L., Wu, H., Li, M., Chen, L., Zhou, Q., Ma, J., Huai, C., Zhou, W., Wei, M., et al. (2023) · Carcinogenesis · doi:10.1093/carcin/bgad068 · Cited by 6
Codon-specific KRAS mutations predict survival in advanced pancreatic cancer
Boilève, A., Rousseau, A., Hilmi, M., Tarabay, A., Mathieu, J. R. R., Cartry, J., Bedja, S., Goudarzi, N., Nicotra, C., Ngo‐Camus, M., et al. (2024) · ESMO Gastrointestinal Oncology · doi:10.1016/j.esmogo.2023.100030 · Cited by 6
Unveiling the Molecular Landscape of Pancreatic Ductal Adenocarcinoma: Insights into the Role of the COMPASS-like Complex
Jamali, M., Barar, E., & Shi, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105069 · Cited by 6
Integrating metabolic profiling of pancreatic juice with transcriptomic analysis of pancreatic cancer tissue identifies distinct clinical subgroups
Pulvirenti, A., Barbagallo, M., Putignano, A. R., Pea, A., Polidori, R., Upstill‐Goddard, R., Cortese, N., Kunderfranco, P., Brunelli, L., Simone, G. D., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1405612 · Cited by 6
Understanding the Conundrum of Pancreatic Cancer in the Omics Sciences Era
Nicoletti, A., Paratore, M., Vitale, F., Negri, M., Quero, G., Esposto, G., Mignini, I., Alfieri, S., Gasbarrini, A., Zocco, M. A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147623 · Cited by 8
Unveiling FKBP7 as an early endoplasmic reticulum sentinel in pancreatic stellate cell activation, collagen remodeling and tumor progression
Quémerais, C., Jean, C., Brunel, A., Decaup, E., Labrousse, G., Audureau, H., Raffenne, J., Belhabib, I., Cros, J. F., Perraud, A., et al. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217538 · Cited by 7
Self-citation
Preoperative Prognostic Factors in Resectable Pancreatic Cancer: State of the Art and Prospects
Boubaddi, M., Rossi, J., Marichez, A., Marty, M., Amintas, S., Laurent, C., & Dabernat, S. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-025-17062-w · Cited by 6
Proteomic analysis of pancreatic ductal adenocarcinoma
Meleady, P., Rahman, R. A., Henry, M. A., Moriarty, M. J., & CLYNES, M. M. (2020) · Expert Review of Proteomics · doi:10.1080/14789450.2020.1803743 · Cited by 6
DECONbench: a benchmarking platform dedicated to deconvolution methods for tumor heterogeneity quantification
Decamps, C., Arnaud, A., Petitprez, F., Ayadi, M., Baurès, A., Armenoult, L., Alcala, N., Arnaud, A., Cobos, F. A., Batista, L., et al. (2021) · BMC Bioinformatics · doi:10.1186/s12859-021-04381-4 · Cited by 8
Self-citation
Stabilization of the classical phenotype upon integration of pancreatic cancer cells into the duodenal epithelium
Bozóky, B., Moro, C. F., Strell, C., Geyer, N., Heuchel, R. L., Löhr, M. J., Ernberg, I. T., Székely, L., Gerling, M., & Bozóky, B. (2021) · Neoplasia · doi:10.1016/j.neo.2021.11.007 · Cited by 6
Machine learning algorithm integrates bulk and single-cell transcriptome sequencing to reveal immune-related personalized therapy prediction features for pancreatic cancer
Zang, L., Zhang, B., Zhou, Y., Zhang, F., Tian, X., Tian, Z., Chen, D., & Miao, Q. (2023) · Aging · doi:10.18632/aging.205293 · Cited by 6
Molecular and cellular heterogeneity of gastric cancer explained by methylation-driven key regulatorsPreprint
Yoo, S., Chen, Q., Wang, L., Wang, W., Chakravarthy, A., Busuttil, R. A., Boussioutas, A., Liu, D., She, J., Fenton, T. R., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.27.920744 · Cited by 6
c-Rel drives pancreatic cancer metastasis through fibronectin-integrin signaling-induced isolation stress resistance and EMT
Bakırdöğen, D., Görgülü, K., Xin, J., Richter, L., Alcalá, S., Ruíz-Cañas, L., Dai, C., Frank, K. J., Wu, N., Diakopoulos, K. N., et al. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02486-5 · Cited by 5
Updates in Molecular Profiling of Pancreatic Ductal Adenocarcinoma
Lee, J. J., & Yeh, J. J. (2024) · Surgical Clinics of North America · doi:10.1016/j.suc.2024.04.001 · Cited by 5
Strategic insights into the cultivation of pancreatic cancer organoids from endoscopic ultrasonography-guided biopsy tissue
Yang, J., Zhang, J., Gu, J., Gao, M., Zheng, M.-Y., Guo, S.-X., & Zhang, T. (2024) · World Journal of Gastroenterology · doi:10.3748/wjg.v30.i42.4532 · Cited by 5
Tumor-Infiltrating Leukocyte Phenotypes Distinguish Outcomes in Related Patients With Pancreatic Adenocarcinoma
Link, J. M., Liudahl, S. M., Betts, C. B., Sivagnanam, S., Leis, K. R., McDonnell, M., Pelz, C., Johnson, B., Hamman, K. J., Keith, D., et al. (2021) · JCO Precision Oncology · doi:10.1200/po.20.00287 · Cited by 3
Tumor budding and fibrotic focus—proposed grading system for tumor budding in invasive carcinoma no special type of the breast
Hiratsuka, M., Hasebe, T., Ichinose, Y., Sakakibara, A., Fujimoto, A., Wakui, N., Shibasaki, S., Hirasaki, M., Yasuda, M., Nukui, A., et al. (2022) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-022-03337-0 · Cited by 5
A novel preoperative MRI-based radiomics nomogram outperforms traditional models for prognostic prediction in pancreatic ductal adenocarcinoma.
Qiu, H., Xu, M., Wang, Y., Wen, X., Chen, X., Liu, W., Zhang, N., Ding, X., & Zhang, L. (2022) · PubMed Central · Cited by 5
Clinicopathologic and Molecular Features of Pancreatic Ductal Adenocarcinomas Harboring Alterations in COMPASS-like Complex Genes
Hissong, E. M., Zhao, L., & Shi, J. (2022) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2022-0103-oa · Cited by 5
GCNA-Cluster: A Gene Co-Expression Network Alignment to Cluster Cancer Patients Algorithm for Identifying Subtypes of Pancreatic Ductal Adenocarcinoma
Yang, J., Lu, Z., Xu, C., Xu, D., Ding, D., & Ding, Y. (2023) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2023.3300102 · Cited by 5
Development of Clinical Radiomics-Based Models to Predict Survival Outcome in Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study
Mokhtari, A., Casale, R., Salahuddin, Z., Paquier, Z., Guiot, T., Woodruff, H. C., Lambin, P., Laethem, J. V., Hendlisz, A., & Bali, M. A. (2024) · Diagnostics · doi:10.3390/diagnostics14070712 · Cited by 7
A protein-based machine learning approach to the identification of inflammatory subtypes in pancreatic ductal adenocarcinoma
Herremans, K. M., Underwood, P. W., Riner, A. N., Neal, D. W., Tushoski-Alemán, G. W., Forsmark, C. E., Nassour, I., Han, S., & Hughes, S. J. (2023) · Pancreatology · doi:10.1016/j.pan.2023.06.007 · Cited by 5
Nutrient profiling reveals extracellular uridine as a fuel for pancreatic cancer through uridine phosphorylase 1Preprint
Ward, M. H., Nwosu, Z. C., Poudel, P., Kasperek, S., Tolstyka, Z., Menjivar, R. E., Ragulan, C., Nyamundanda, G., Zhang, L., Andren, A. C., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.06.07.447448 · Cited by 5
Clonal Heterogeneity in Human Pancreatic Ductal Adenocarcinoma and Its Impact on Tumor ProgressionPreprint
Kalfakakou, D., Cameron, D. C., Kawaler, E. A., Tsuda, M., Wang, L., Jing, X., Hajdu, C. H., Tamayo, D. L., Shim, Y., Ackermann, A., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.11.637729 · Cited by 5
Functional Precision in Pancreatic Cancer: Redefining Biomarkers with Patient-Derived Organoids
Chew, C. A. Z., Wun, C. M., Lee, Y. F., Chee, C. E., Ho, K. Y., & Bonney, G. K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189083 · Cited by 4
IGF2BP2 stabilized by USP7 promotes cancer-associated fibroblast activation and attenuates gemcitabine sensitivity in PDAC
Ge, F., Zhu, H., Liu, X., Li, Y., Guo, R., Zeng, C., Yuan, T., Yang, L., Dong, X., Wu, Y., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116476 · Cited by 4
Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after neoadjuvant FOLFIRINOX followed by high-dose stereotactic body radiotherapy
Bouchart, C., Senar, O. A., Navez, J., Verset, L., Boisson, A., Hein, M., Stosic, K., Quertinmont, E., Tafciu, V., Zhao, S., et al. (2026) · British Journal of Cancer · doi:10.1038/s41416-025-03274-0 · Cited by 4
Self-citation
Molecular subtypes in pancreatic cancer: from academic promise to clinical reality
Altimari, D. M. D., Bevere, M., Espinet, E., Martineau, Y., Giovannetti, E., & Lobo, V. J. S.-A. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02614-9 · Cited by 5
A peritumoral microenvironment engaged by Reg-EXTL3 axis fosters nerve-cancer interactions in pancreatic ductal adenocarcinoma
Zhang, S., Dong, F.-Y., Cai, S., Zhou, B., Jiang, L., Hu, L.-P., Zhu, Y.-H., Li, H., Yang, X., Cai, Z., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.03.039 · Cited by 4
Minute virus of mice shows oncolytic activity against pancreatic cancer cells exhibiting a mesenchymal phenotype
Vienne, M., Lopez, C., Lulka, H., Nevot, A., Labrousse, G., Dusetti, N., Buscail, L., & Cordelier, P. (2024) · Molecular Therapy Oncology · doi:10.1016/j.omton.2024.200780 · Cited by 4
Prognostic and therapeutic value of the Eph/Ephrin signaling pathway in pancreatic cancer explored based on bioinformatics
Liu, J., Yuan, Q., Chen, X., Yang, Y., Xie, T., Zhang, Y., Qi, B., Li, S., & Shang, D. (2024) · Scientific Reports · doi:10.1038/s41598-024-68385-9 · Cited by 4
Weighted gene co-expression network analysis reveals key stromal prognostic markers in pancreatic cancer
Mantini, G., Agostini, A., Tufo, M., Rossi, S., Kulesko, M., Carbone, C., Salvatore, L., Tortora, G., Scambia, G., & Giacò, L. (2024) · Scientific Reports · doi:10.1038/s41598-024-82563-9 · Cited by 4
KRAS mutation status integrated with RNA subtyping improves prognostic modeling in FOLFIRINOX-treated metastatic pancreatic cancer
Lansbergen, M. F., Dings, M. P. G., Köster, J., Labots, M., Kerver, E. D., Jochems, A., Homs, M. Y. V., de Vos‐Geelen, J., Hendriks, M. P., Tanck, M. W. T., et al. (2025) · Med · doi:10.1016/j.medj.2025.100601 · Cited by 5
Transcriptome profiling reveals liver metastasis-associated genes in pancreatic ductal adenocarcinoma
Yu, Y., Wang, Z., Mo, D. H., Wang, Z., & Li, G. (2021) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2021088 · Cited by 4
The novel subclusters based on cancer-associated fibroblast for pancreatic adenocarcinoma
Zhao, G., Wang, C., Jiao, J., Zhang, W., & Yang, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1045477 · Cited by 4
Targeted transcriptomic analysis of pancreatic adenocarcinoma in EUS-FNA samples by NanoString technology
Pedrosa, L., Araujo, I. K., Cuatrecasas, M., Soy, G., López‐Prades, S., Maurel, J., Sánchez-Montes, C., Montironi, C., Saurí, T., Sendino, O., et al. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1161893 · Cited by 5
Strategies for the Management of Patients with Pancreatic Cancer with PARP Inhibitors
Golan, T., Raitses‐Gurevich, M., Beller, T., Carroll, J. R., & Brody, J. R. (2023) · Cancer treatment and research · doi:10.1007/978-3-031-30065-3_8 · Cited by 4
Predictive Values of Blood-Based RNA Signatures for the Gemcitabine Response in Advanced Pancreatic Cancer
Piquemal, D., Noguier, F., Pierrat, F., Bruno, R., & Cros, J. F. (2020) · Cancers · doi:10.3390/cancers12113204 · Cited by 4
Self-citation
Combined tumor epithelial and stromal histopathology with keratin 81 expression predicts prognosis for pancreatic ductal adenocarcinoma
Park, E., Yoo, J. E., Hwang, H. K., Kang, C. M., Lee, C., Kim, M. H., Bang, S., & Park, Y. N. (2021) · Journal of Hepato-Biliary-Pancreatic Sciences · doi:10.1002/jhbp.1025 · Cited by 4
Prognostic and immunotherapeutic potential of disulfidptosis-associated signature in pancreatic cancer
Cui, R., Wang, G., Hu, R.-H., Wang, Y., Mu, H., Song, Y., Chen, B., & Jiang, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1568976 · Cited by 3
Molecular Pathology of Pancreatic Ductal Adenocarcinoma
Shalaby, A. S., Sadri, N., & Xue, Y. (2025) · Cancers · doi:10.3390/cancers17213549 · Cited by 3
Druggable genome CRISPR screening identifies the KEAP1/NRF2 axis as a mediator of PD-L1 expression
Seker-Polat, F., Rogozinska, M., Ban, Y. H., Abdula, F., Buyukcelebi, K., Xie, P., Fan, J., Abbaszadeh, N., Kingham, Y., Paylakhi, S. Z., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08983-z · Cited by 3
Single-cell and spatial transcriptomics reveal the interaction between PRRX2-driven epithelial cells and SPP1+ macrophages in mediating gemcitabine resistance in pancreatic ductal adenocarcinoma
Liu, J., Li, Z., Liu, G., Pei, Z., Liu, W. G., Yang, W., Li, F., & Huo, L. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003966 · Cited by 3
Prehabilitation as a Biologically Active Intervention Is Associated with the Remodeling of the Pancreatic Tumor-Immune Microenvironment
Stubbins, R., Li, B., Vasquez, M., Gorman, B. K., Zambelas, J. M., Allenson, K., Dhala, A. F., Dong, W., Zhao, H., & Wong, S. T. C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020943 · Cited by 3
Toward precision chemotherapy in pancreatic ductal adenocarcinoma: molecular, transcriptomic and clinical determinants
Capurso, G., Garajová, I., Neuzillet, C., Leta, L. C., Dusetti, N., & Reni, M. (2026) · Digestive and Liver Disease · doi:10.1016/j.dld.2026.02.020 · Cited by 3
Tumor cell-derived HSP47 promotes pancreatic Cancer metastasis via Homotrimeric collagen-mediated M2 macrophage polarization
Ling, X., Zhang, Y., Zhu, L., Xu, Z., Bao, Y., Lin, H., Wu, J., Shi, J., Liu, L., & Dong, Q. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112589 · Cited by 3
The xenobiotic transporter ABCC4/MRP4 promotes epithelial mesenchymal transition in pancreatic cancer
Gancedo, S. N., Sahores, A., Gómez, N., Siervi, N. D., May, M., Yaneff, A., Serro, M. D. S., Fraunhoffer, N. A., Dusetti, N., Iovanna, J., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1432851 · Cited by 3
Self-citation
Explainable multi-omics deep clustering model reveals an important role of DNA methylation in pancreatic ductal adenocarcinoma
Lopez, A., Zobolas, J., Lingjærde, O. C., Nebdal, D. J. H., Fleischer, T., & Aittokallio, T. A. (2024) · Nordic Machine Intelligence · doi:10.5617/nmi.10584 · Cited by 3
The enhanced cell cycle related to the response to adjuvant therapy in pancreatic ductal adenocarcinoma
Mao, Y., Cheng, W., Yang, Q., Li, L., Hu, W., Shuang, Z., Fan, D., Jiang, X., Gao, F., Li, S., et al. (2021) · Genomics · doi:10.1016/j.ygeno.2021.11.036 · Cited by 3
Replication stress identifies novel molecular classification associated with treatment outcomes in pancreatic cancer
Zhou, Z., Saluja, A. K., Houchen, C. W., & Li, M. (2022) · Pancreatology · doi:10.1016/j.pan.2022.11.008 · Cited by 3
Integrated analysis of scRNA-seq and bulk RNA-seq reveals that GPRC5A is an important prognostic gene in pancreatic cancer and is associated with B-cell Infiltration in pancreatic cancer
Dong, C., Ma, H., Mi, N., Fu, W., Yi, J., Gao, L., Wang, H., Ren, Y., Lin, Y., Han, F., et al. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1283164 · Cited by 3
New Onset Diabetes in Pancreatic Adenocarcinoma Does Not Correlate With Molecular Subtype
Trembath, H. E., LaBella, M. E., Kearney, J. F., Hariharan, A., Zarmer, S., Nabors, M., McCabe, I. C., Zhao, R. T., Meyers, M. O., Kim, H. J., et al. (2024) · Journal of Surgical Oncology · doi:10.1002/jso.28044 · Cited by 3
Immunotherapeutic Approach for Advanced Pancreatic Adenocarcinoma
Kaur, J., Mir, T., Gill, R., Duong, J., Marcus, S., & Khan, R. (2021) · Immunotherapy · doi:10.2217/imt-2020-0344 · Cited by 4
Robust Validation and Comprehensive Analysis of a Novel Signature Derived from Crucial Metabolic Pathways of Pancreatic Ductal Adenocarcinoma
Gu, W., Mo, S., Wang, Y., Kawabata‐Iwakawa, R., Zhang, W., Yang, Z., Sun, C., Tsushima, Y., Xu, H., & Nakajima, T. (2022) · Cancers · doi:10.3390/cancers14071825 · Cited by 3
Morphological and p40 immunohistochemical analysis of squamous differentiation in endoscopic ultrasound guided fine needle biopsies of pancreatic ductal adenocarcinoma
Haugk, B., Horton, D., Oppong, K. W., Leeds, J. S., Darné, A., Sloan, P., Ness, T., Jones, C., Bassett, P., & Nayar, M. K. (2021) · Scientific Reports · doi:10.1038/s41598-021-00652-5 · Cited by 3
Does biology determine survival in pancreatic cancer?
Barreto, S. G. (2019) · Future Oncology · doi:10.2217/fon-2019-0706 · Cited by 3
Cytidine deaminase protects pancreatic cancer cells from replicative stress and drives resistance to DNA-targeting drugsPreprint
Lumeau, A., Béry, N., Francès, A., Gayral, M., Ribeyre, C., Lopez, C., Nevot, A., Elkaoutari, S., Labrousse, G., Madrid-Mencía, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.23.465566 · Cited by 3
PACpAInt: a deep learning approach to identify molecular subtypes of pancreatic adenocarcinoma on histology slidesPreprint
Saillard, C., Delecourt, F., Schmauch, B., Moindrot, O., Svrcek, M., Bardier–Dupas, A., Emile, J., Ayadi, M., Rebours, V., de Mestier, L., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.04.474951 · Cited by 3
Self-citation
Ongoing Replication Stress Response and New Clonal T Cell Development Discriminate Between Liver and Lung Recurrence Sites and Patient Outcomes in Pancreatic Ductal AdenocarcinomaPreprint
Link, J. M., Pelz, C., Worth, P. J., Owen, S., Keith, D., Langer, E. M., Grossblatt-Wait, A., Creason, A., Egger, J., Holly, H. D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.04.490552 · Cited by 3
Real-world data validation of the PurIST pancreatic ductal adenocarcinoma gene expression classifier and its prognostic implicationsPreprint
Wenric, S., Davison, J. M., Guittar, J. L., Mayhew, G. M., Beebe, K. D., Wang, Y. E., Iyer, A. A., Kang, H. P., Milburn, M. V., Chung, V. M., et al. (2023) · medRxiv · doi:10.1101/2023.02.23.23286356 · Cited by 2
Transcriptomic analysis of laser-capture microdissected tumors reveals RAD51AP1 as a tumor-specific marker associated progression from pancreatic intraepithelial neoplasia to invasive pancreatic cancer
Rezagholizadeh, F., Salimi, A., Sharifi‐Zarchi, A., Azmoudeh-Ardalan, F., Mousavizadeh‬, K., Tajik, F., Panahi, M., Khorramdelazad, H., Wadji, M. B., Kashanizadeh, A., et al. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03810-1 · Cited by 3
Evaluating and Optimizing Mass Spectrometry Proteomics Data to Deconvolve Cell-Type-Specific Protein Expression in Tumors
Song, Y., Zhou, Q. G., & Huang, C. L. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00980 · Cited by 2
Complementary strategies in pancreatic cancer precision medicine: therapeutic prediction and immune modulation
Lee, W., Woo, H.-M., Cho, J. H., & Kim, M. S. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1718911 · Cited by 3
Comprehensive Multitask Ensemble Segmentation and Clinical Interpretation of Pancreatic and Peripancreatic Anatomy With Radiomics and Deep Learning Features
Jiang, M., Hu, J., Zheng, J., Wang, J., & Ye, X.-H. (2025) · International Journal of Imaging Systems and Technology · doi:10.1002/ima.70270 · Cited by 2
Novel Acinar Metaplastic States Uncovered in Exocrine Pancreas Disease
Aney, K. J., Jeong, W., Koak, P., Öhman, A., Nguyen, C. H., Wolpin, B. M., Nowak, J. A., & Nissim, S. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101717 · Cited by 2
Epigenetic Regulators as Therapeutic Targets in Pancreatic Ductal Adenocarcinoma
Kubiak, K., & Inkielewicz‐Stępniak, I. (2026) · Cancers · doi:10.3390/cancers18061001 · Cited by 2
Precision Medicine in Pancreatic Cancer: Targeting KRAS and Beyond
Schürmann, H., Park, W., O'Kane, G. M., Sciortino, C., Niger, M., Reichert, M., Olive, K. P., Pretzell, I., & Westphalen, C. B. (2026) · Targeted Oncology · doi:10.1007/s11523-026-01236-x · Cited by 2
Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic Cancer
Beaufils, A., de Martino, J., Jiang, X. Y., Blanchard, T., Fraunhoffer, N. A., Mendes, D., Pignolet, C., Bourega, T. A., Meneghetti, A. R., Sainath, S., et al. (2026) · Journal of Clinical Oncology · doi:10.1200/jco-26-00327 · Cited by 2
Self-citation
Management of Advanced Pancreatic Cancer through Stromal Depletion and Immune Modulation
Liu, T., Cheng, S., Xu, Q., & Wang, Z. P. (2022) · Medicina · doi:10.3390/medicina58091298 · Cited by 2
Poor-prognosis molecular subtypes in adenocarcinomas of pancreato-biliary and gynecological origin: A systematic review
Lansbergen, M. F., Khelil, M., van Etten‐Jamaludin, F. S., Bijlsma, M. F., & van Laarhoven, H. W. M. (2023) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2023.103982 · Cited by 2
Identification of Nectin Family Interactive Gene Panel and Stratification of Clinical Outcomes in Patients with Pancreatic Cancer
Imazu, Y., Nishiwada, S., Yasuda, S., Nagai, M., Nakamura, K., Matsuo, Y., Terai, T., Yoshida, C., Kohara, Y., & Sho, M. (2023) · Journal of the American College of Surgeons · doi:10.1097/xcs.0000000000000808 · Cited by 2
Cytokines and Pancreatic Ductal Adenocarcinoma: Exploring Their Relationship with Molecular Subtypes and Prognosis
Gutiérrez-Sainz, L., Heredia-Soto, V., Rodríguez, A., Sánchez, M. G. C., Olmedo, M., Molero-Luís, M., Losantos-García, I., Ghanem, I., Pérez-Wert, P., Custodio, A. B., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179368 · Cited by 2
Threading the Needle: Navigating Novel Immunotherapeutics in Pancreatic Ductal Adenocarcinoma
Demir, T., Moloney, C., & Mahalingam, D. (2025) · Cancers · doi:10.3390/cancers17050715 · Cited by 2

Authors: Puleo, F., Nicolle, R., Blum, Y., Cros, J., Marisa, L., Demetter, P., Quertinmont, E., Svrcek, M., Elarouci, N., Iovanna, J., Franchimont, D., Verset, L., Galdon, M. G., Devière, J., de Reyniès, A., Laurent-Puig, P., Van Laethem, J.-L., Bachet, J.-B., & Maréchal, R.
Affiliations: Université Libre de Bruxelles (BE)
La Ligue Contre le Cancer (FR)
Erasmus Hospital (BE)
Hôpital Saint-Antoine (FR)
Centre National de la Recherche Scientifique (FR)
Pitié-Salpêtrière Hospital (FR)
Corresponding author: Puleo, Francesco
ORCID: Puleo, Francesco
Nicolle, Rémy
Blum, Yuna
Marisa, Laetitia
Demetter, Pieter
Quertinmont, Eric
Svrcek, Magali
Elarouci, Nabila
Iovanna, Juan
Franchimont, Denis
Verset, Laurine
Galdon, Maria Gomez
Laurent-Puig, Pierre
Bachet, Jean-Baptiste
Venue: Gastroenterology
Publisher: Elsevier BV
Published: 2018-12
Volume: 155
Issue: 6
Pages: 1999-2013.e3
ISSN: 0016-5085 (ISSN-L)
DOI: 10.1053/j.gastro.2018.08.033
OpenAlex: W2889433609
Cited by: 563
References: 34
Citations by year: 2026: 53 · 2025: 63 · 2024: 66 · 2023: 87 · 2022: 81 · 2021: 109 · 2020: 72 · 2019: 28 · 2018: 4
FWCI: 20.20
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Gastroenterology (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
Topics: Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords: pancreatic ductal adenocarcinoma, tumor subtypes, tumor microenvironment, gene expression profiling, formalin-fixed paraffin-embedded tissue, desmoplasia, basal-like subtype, classical subtype, overall survival, disease-free survival, independent component analysis, consensus clustering
MeSH terms: Progression-Free Survival, Adenocarcinoma, Adult, Aged, Aged, 80 and over, DNA, Neoplasm, Female, Humans, Male, Middle Aged, Pancreas, Prospective Studies, Regression Analysis, RNA, Neoplasm, Gene Expression, Proportional Hazards Models, Sequence Analysis, DNA, Disease-Free Survival, Carcinoma, Pancreatic Ductal, Pancreas, Exocrine, Tumor Microenvironment, Transcriptome, Acinar Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks